Literature DB >> 18443126

Synergy of human immunodeficiency virus protease inhibitors with chloroquine against Plasmodium falciparum in vitro and Plasmodium chabaudi in vivo.

Zhengxiang He1, Li Qin, Lili Chen, Nanzheng Peng, Jianlan You, Xiaoping Chen.   

Abstract

The synergy of the activities between chloroquine and various human immunodeficiency virus protease inhibitors was investigated in chloroquine-resistant and -sensitive malaria parasites. In both in vitro and in vivo assay systems, ritonavir was found to be the most potent in potentiating the antimalarial action of chloroquine.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18443126      PMCID： PMC2443913          DOI： 10.1128/AAC.01329-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Is reversal of chloroquine resistance ready for the clinic?

Authors:  S A Ward; P G Bray
Journal:  Lancet       Date:  2001-03-24       Impact factor: 79.321

Review 2.  Antimalarial drug discovery: efficacy models for compound screening.

Authors:  David A Fidock; Philip J Rosenthal; Simon L Croft; Reto Brun; Solomon Nwaka
Journal:  Nat Rev Drug Discov       Date:  2004-06       Impact factor: 84.694

3.  Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.

Authors:  Quinton L Fivelman; Ipemida S Adagu; David C Warhurst
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

4.  Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.

Authors:  T S Skinner-Adams; K T Andrews; L Melville; J McCarthy; D L Gardiner
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

5.  HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo.

Authors:  Takayuki Ikezoe; Yasuko Hisatake; Tamotsu Takeuchi; Yuji Ohtsuki; Yang Yang; Jonathan W Said; Hirokuni Taguchi; H Phillip Koeffler
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

6.  Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors.

Authors:  Andrea Savarino; Mothanje B Lucia; Elena Rastrelli; Sergio Rutella; Caterina Golotta; Emanuella Morra; Enrica Tamburrini; Carlo Federico Perno; Johan R Boelaert; Kirk Sperber; Roberto Cauda
Journal:  J Acquir Immune Defic Syndr       Date:  2004-03-01       Impact factor: 3.731

7.  Chloroquine resistance in Plasmodium chabaudi: are chloroquine-resistance transporter (crt) and multi-drug resistance (mdr1) orthologues involved?

Authors:  Paul Hunt; Pedro V L Cravo; Paul Donleavy; Jane M-R Carlton; David Walliker
Journal:  Mol Biochem Parasitol       Date:  2004-01       Impact factor: 1.759

8.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

9.  Synchronization of Plasmodium falciparum erythrocytic stages in culture.

Authors:  C Lambros; J P Vanderberg
Journal:  J Parasitol       Date:  1979-06       Impact factor: 1.276

10.  In vitro and in vivo potentiation of chloroquine against malaria parasites by an enantiomer of amlodipine.

Authors:  P Deloron; L K Basco; B Dubois; C Gaudin; F Clavier; J Le Bras; F Verdier
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191
View more
  20 in total

1.  4-Aryl Pyrrolidines as Novel Orally Efficacious Antimalarial Agents. Part 2: 2-Aryl-N-(4-arylpyrrolidin-3-yl)acetamides.

Authors:  Marvin J Meyers; Jianguang Liu; Zhijun Liu; Hongwei Ma; Linglin Dai; Dickson Adah; Siting Zhao; Xiaofen Li; Xiaorong Liu; Yongzhi Lu; Yanhui Huang; Zhengchao Tu; Xiaoping Chen; Micky D Tortorella
Journal:  ACS Med Chem Lett       Date:  2019-05-28       Impact factor: 4.345

2.  Antimalarial effects of human immunodeficiency virus protease inhibitors in rhesus macaques.

Authors:  Youjia Li; Li Qin; Nanzheng Peng; Guangjie Liu; Siting Zhao; Zhengxiang He; Xiaoping Chen
Journal:  Antimicrob Agents Chemother       Date:  2011-04-12       Impact factor: 5.191

3.  4-Aryl Pyrrolidines as a Novel Class of Orally Efficacious Antimalarial Agents. Part 1: Evaluation of 4-Aryl- N-benzylpyrrolidine-3-carboxamides.

Authors:  Marvin J Meyers; Jianguang Liu; Jing Xu; Fang Leng; Jiantong Guan; Zhijun Liu; Sarah A McNitt; Limei Qin; Linglin Dai; Hongwei Ma; Dickson Adah; Siting Zhao; Xiaofen Li; Alex J Polino; Armiyaw S Nasamu; Daniel E Goldberg; Xiaorong Liu; Yongzhi Lu; Zhengchao Tu; Xiaoping Chen; Micky D Tortorella
Journal:  J Med Chem       Date:  2019-03-22       Impact factor: 7.446

4.  HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study.

Authors:  Kimberly A Porter; Stephen R Cole; Joseph J Eron; Yu Zheng; Michael D Hughes; Shahin Lockman; Charles Poole; Tina S Skinner-Adams; Mina Hosseinipour; Doug Shaffer; Ronald D'Amico; Frederick K Sawe; Abraham Siika; Elizabeth Stringer; Judith S Currier; Tsungai Chipato; Robert Salata; James S McCarthy; Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

Review 5.  Drug interactions in the treatment and chemoprophylaxis of malaria in HIV infected individuals in sub Saharan Africa.

Authors:  Fatai A Fehintola; Olusegun O Akinyinka; Isaac F Adewole; Chiedza C Maponga; Qing Ma; Gene D Morse
Journal:  Curr Drug Metab       Date:  2011-01       Impact factor: 3.731

6.  Synergy of the antiretroviral protease inhibitor indinavir and chloroquine against malaria parasites in vitro and in vivo.

Authors:  Xiaofen Li; Zhengxiang He; Lili Chen; Yayong Li; Qinyan Li; Siting Zhao; Zhu Tao; Wen Hu; Li Qin; Xiaoping Chen
Journal:  Parasitol Res       Date:  2011-05-03       Impact factor: 2.289

7.  In vitro activity of antiretroviral drugs against Plasmodium falciparum.

Authors:  Christian Nsanzabana; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

8.  Asexual and sexual stages of Plasmodium falciparum in Nigerian pregnant women attending antenatal booking clinic.

Authors:  S T Balogun; F A Fehintola; O A Adeyanju; A A Adedeji
Journal:  Obstet Med       Date:  2010-09-17

9.  Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.

Authors:  Pedro A Moura; John B Dame; David A Fidock
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.191

10.  Comparative study of chloroquine and quinine on malaria rodents and their effects on the mouse testis.

Authors:  Esmail Abolghasemi; Seyed Hassan Moosa-Kazemi; Maryam Davoudi; Ahmad Reisi; Mohammad Taghi Satvat
Journal:  Asian Pac J Trop Biomed       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.